Organization
Halozyme Therapeutics, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Halozyme Therapeutics, Inc.
... latest key findings for all current investors, traders, and shareholders of Halozyme Therapeutics, Inc. (NASDAQ:HALO), Fitbit, Inc. (NYSE:FIT), Iconix Brand Group, Inc. (NASDAQ:ICON), Leap Therapeutics, ...
... PR Newswire Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, will ...
... Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, today ...
... Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies will ...
... Biotechnology company Halozyme Therapeutics Inc (NASDAQ:HALO ) stated on Monday that it has Health Canada approval for ...
... Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that Roche has received approval from Health Canada ...
... roles at Bristol-Myers Squibb over a period of 12 years. Release > Halozyme Therapeutics brought onBenjamin Hickey as chief commercial officer. At Bristol-Myers Squibb, Hickey ...
... Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, today ...
Subscribe now for full coverage on Halozyme Therapeutics, Inc.
Start My Free Trial